ClinicalTrials.Veeva

Menu

Influence of Sedentary Time on Skeletal Muscle Protein Metabolism

U

University of Birmingham

Status

Completed

Conditions

Sedentary Lifestyle

Treatments

Behavioral: 7 days of habitual physical activity followed by 7 days of reduced physical activity

Study type

Interventional

Funder types

Other

Identifiers

NCT02624011
ERN_15-1238

Details and patient eligibility

About

This study will investigate the influence of increased sedentary time on long-term measures of muscle protein synthesis and metabolic health. The investigators will test the hypothesis that increased time spent in sedentary behaviours will lead to a reduction in long-term measures of muscle protein synthesis and compromised metabolic health.

Full description

Sarcopenia, the loss of muscle mass with age, is thought to be accelerated by an inactive, sedentary lifestyle. Increased sedentary time has consistently been associated with lower muscle mass and compromised metabolic health. However, there is currently a lack of direct evidence to support these associations.

Therefore, this study will investigate whether increased sedentary time (reduced step count and exercise cessation) directly influences long-term measures of muscle protein synthesis and metabolic health in young, active adults. Following a 7 day period of normal habitual physical activity, participants will undertake a 7 day period of step reduction and exercise cessation. It is hypothesised that 7 days of increased sedentary time will result in a reduction in long-term rates of muscle protein synthesis and a worsening of metabolic health.

Enrollment

8 patients

Sex

Male

Ages

18 to 35 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Body mass index (18.5-29.99 kg/m2)
  • Active - defined as: ≥ 7000 steps per day (assessed during screening) and taking part in regular exercise (defined as participation in ≥ 3 sessions of aerobic and/or resistance exercise type sessions a week for ≥ 6 months prior to recruitment)
  • Good general health

Exclusion criteria

  • Lidocaine allergy
  • Hypertension (≥140/90 mmHg)
  • Current participation in another clinical study
  • Previous participation in this study
  • Bleeding disorder/s
  • Current or recent smoker
  • Past history of substance abuse and/or taking prescription or non-prescription medication (e.g., beta-blockers, insulin or thyroxine) or supplements that may influence normal metabolic responses.
  • Participants who have previously (within 5 years of the present study) had 4 or more muscle biopsies obtained from the thigh quadriceps region will be ineligible.

Trial design

Primary purpose

Basic Science

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

8 participants in 1 patient group

Physical inactivity
Experimental group
Description:
Study arm consisting of 7 days of habitual physical activity followed by 7 days of step reduction and exercise cessation.
Treatment:
Behavioral: 7 days of habitual physical activity followed by 7 days of reduced physical activity

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems